The Biopharmaceuticals MSc is an advanced study programme that will provide chemical, life science and pharmacy graduates with the scientific knowledge and expertise in the areas of biopharmaceutical discovery and development needed for careers in the pharmaceutical and biotech industry, research institutes or regulatory authorities.
Links with the pharmaceutical industry in terms of visiting lecturers and site visits.
King's is ranked 7th in the world for Pharmacy & Pharmacology (QS World University Rankings by Subject 2017)
Advanced study programme focusing on the discovery and development of biopharmaceuticals, therapeutic peptides, protein, monoclonal antibodies and nucleic acids.
This course was designed to address the growing needs of the Biotech industry. The Biopharmaceuticals MSc course is an interdisciplinary course of study with the aim of developing medicines for the future. The subject areas will include drug delivery & disposition and pharmaceuticals analysis followed by more specialised studies on the discovery of peptides, proteins and antibody therapeutics and their development into medicines.
An integral component of the course is a laboratory research dissertation worth 60 credits where you will work in a research laboratory involved with independent research supervised by experts in the field.
Course format and assessment
We use lectures, seminars and group tutorials to deliver most of the modules on the programme. You will also be expected to undertake a significant amount of independent study.
You are assessed through a combination of the following methods:
Laboratory assessment (30%)
Written examination (70%)
Production of research paper (50%)
Literature review (20%)
Laboratory record (10%)
Laboratory performance (10%)
The study time and assessment methods detailed above are typical and give you a good indication of what to expect.
Recent graduates have gone on to work in research and development laboratories in the Pharmaceutical and Biopharmaceutical Industries. Employers include Pfizer, GSK and Novartis and small Biotech companies. Overseas students have returned to similar positions in their home countries. Other graduates choose to continue to study towards a PhD.